Skip to main content
Quest Diagnostics

The Autoantigen TRIM21 Assembles Proinflammatory Immune Complexes After Lytic Cell Death

The Autoantigen TRIM21 Assembles Proinflammatory Immune Complexes After Lytic Cell Death

Authors: Jones Evans EL, Demarco B, Cai H, de Jong MME, Hill S, Widdess MA, Fergusson JR, Glass RE, Harris G, Mead GJ, Yazicioglu YF, Nayar S, Fisher BA, Cragg MS, Clarke AJ, Gérard A, Bezbradica JS, Dustin LB

Citation: Sci Immunol. 2026 Apr 17;11(118):eads9680. doi: 10.1126/sciimmunol.ads9680.

Specialties: Immunology

Related content

On-Demand Webinar
Lab Testing for Overlapping Rheumatic Diseases: A Comprehensive Approach
Test FAQ
Tests for Autoimmune Diseases
On-Demand Webinar
Autoimmune Disease and Cardiometabolic Risk
Test FAQ
Lupus Anticoagulant (LA) Evaluation with Reflex
Test FAQ
Antiphospholipid Antibodies
Publication
Multiple Malignancy-Associated Dermatomyositis Myositis-Specific Autoantibodies in Dermatomyositis

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.